Prokidney (PROK) Net Margin (2024 - 2026)
Prokidney's (PROK) quarterly Net Margin came in at 30957.33% in Q2 2026, down 1423109.0% year-over-year from N/an in Q2 2025, and down 64.15% quarter-over-quarter from 18858.85% in Q1 2026.
Powered by 
Analysis
Prokidney (PROK) Net Margin (2024 - 2026) Analysis & Trends
Prokidney (PROK) has reported Net Margin for 3 consecutive years, with 30957.33% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Margin fell 1423109.0% year-over-year to 30957.33% in Q2 2026; TTM through Jun 2026 was 16330.81%, a 1487470.0% increase from a year earlier, with the FY2025 full-year figure at 7725.2%, up 7278270.0% from the prior year.
- Net Margin was 30957.33% for Q2 2026 at Prokidney, down from 18858.85% in the prior quarter.
- Over five years, Net Margin peaked at 3860.44% in Q4 2025 and troughed at 63793.42% in Q4 2024.
- A 3-year average of 23887.81% and a median of 16726.24% in 2025 frame the typical range for Net Margin.
- Across the five-year window, Net Margin soared 5993298 bps in 2025 and tumbled 1423109 bps in 2026, its largest moves.
- Over 3 years, Net Margin stood at 63793.42% in 2024, then jumped by 94 bps to 3860.44% in 2025, then tumbled by 702 bps to 30957.33% in 2026.
- The last three Net Margin figures came in at 30957.33% (Q2 2026), 18858.85% (Q1 2026), and 3860.44% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn | 45.94% |
| 2 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - | -895.73% |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn | -47.62% |
| 4 | Legend Biotech | 3.67 Bn | 2.71 Bn | 251.50 Mn | 20.08% |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -1,387.76% |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -25,036.33% |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 36.51% |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -1.22% |
| 9 | Vericel | 1.98 Bn | 1.81 Bn | 56.40 Mn | 2.88% |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | -30,957.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -30,957.33% |
| Mar 31, 2026 | -18,858.85% |
| Dec 31, 2025 | -3,860.44% |
| Sep 30, 2025 | -16,517.51% |
| Jun 30, 2025 | -16,726.24% |
| Mar 31, 2025 | -16,500.87% |
| Dec 31, 2024 | -63,793.42% |